文献简介

出版社:International Immunopharmacology

作  者:R.L. Miller, M.A. Tomai, C.J. Harrison, D.I. Bernstein

编  号:

关键字:

年  份:2002   点击量:692

文献摘要

Abstract
      In this review, we discuss the ongoing development of a new treatment option for genital herpes (GH), the disease caused by herpes simplex virus (HSV) types I and II. Following infection, the virus establishes a latent infection in peripheral neurons, which periodically activates to cause recurrent skin lesions or asymptomatic shedding in the anogenital area.